Cargando…

A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report

BACKGROUND: Clinical studies on the effects of thalidomide‐induced damage on thalidomide victims as they age have only recently started to be conducted, but no studies have examined socioeconomic differences in terms of healthcare and social status between thalidomiders and the age‐matched general p...

Descripción completa

Detalles Bibliográficos
Autores principales: Hinoshita, Fumihiko, Beppu, Hiroko, Shioji, Shingo, Fujitani, Junko, Imai, Koubun, Tajima, Tsuyoshi, Tagami, Tetsuya, Ohnishi, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432171/
https://www.ncbi.nlm.nih.gov/pubmed/31339667
http://dx.doi.org/10.1002/bdr2.1558
_version_ 1783571738520453120
author Hinoshita, Fumihiko
Beppu, Hiroko
Shioji, Shingo
Fujitani, Junko
Imai, Koubun
Tajima, Tsuyoshi
Tagami, Tetsuya
Ohnishi, Shin
author_facet Hinoshita, Fumihiko
Beppu, Hiroko
Shioji, Shingo
Fujitani, Junko
Imai, Koubun
Tajima, Tsuyoshi
Tagami, Tetsuya
Ohnishi, Shin
author_sort Hinoshita, Fumihiko
collection PubMed
description BACKGROUND: Clinical studies on the effects of thalidomide‐induced damage on thalidomide victims as they age have only recently started to be conducted, but no studies have examined socioeconomic differences in terms of healthcare and social status between thalidomiders and the age‐matched general population in Japan. Therefore, we carried out a nationwide survey focusing on the life situations of thalidomiders. METHOD: Questionnaires were sent to 274 thalidomiders in Japan. The questionnaire items basically matched those of the Comprehensive Survey of Living Conditions (CSLC) in the general population conducted by the Japanese Government. The results were compared with those of the CSLC for individuals aged 55–59 years, which was the cohort most similar in age to the average thalidomider living in Japan. RESULTS: More thalidomiders rated their health condition as relatively bad or bad compared with the general population (20.2% vs. 13.3%, respectively). A much higher percentage of thalidomiders reported having some health or physical problem caused by a disease or injury (68.8% vs. 32.6%, respectively), and thalidomiders reported visiting medical and healthcare‐related facilities more frequently. A higher proportion of thalidomiders (9.2%) were unemployed, and thalidomiders tended to feel higher levels of worry and stress, especially in terms of the future. CONCLUSIONS: The results of this nationwide survey of the life situations of thalidomiders in Japan clarified their health conditions and the related associations with socioeconomic status. These findings could be expected to help improve the provision of medical and healthcare, welfare measures, and financial support for thalidomiders in the near future.
format Online
Article
Text
id pubmed-7432171
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Inc.
record_format MEDLINE/PubMed
spelling pubmed-74321712020-08-20 A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report Hinoshita, Fumihiko Beppu, Hiroko Shioji, Shingo Fujitani, Junko Imai, Koubun Tajima, Tsuyoshi Tagami, Tetsuya Ohnishi, Shin Birth Defects Res Research Articles BACKGROUND: Clinical studies on the effects of thalidomide‐induced damage on thalidomide victims as they age have only recently started to be conducted, but no studies have examined socioeconomic differences in terms of healthcare and social status between thalidomiders and the age‐matched general population in Japan. Therefore, we carried out a nationwide survey focusing on the life situations of thalidomiders. METHOD: Questionnaires were sent to 274 thalidomiders in Japan. The questionnaire items basically matched those of the Comprehensive Survey of Living Conditions (CSLC) in the general population conducted by the Japanese Government. The results were compared with those of the CSLC for individuals aged 55–59 years, which was the cohort most similar in age to the average thalidomider living in Japan. RESULTS: More thalidomiders rated their health condition as relatively bad or bad compared with the general population (20.2% vs. 13.3%, respectively). A much higher percentage of thalidomiders reported having some health or physical problem caused by a disease or injury (68.8% vs. 32.6%, respectively), and thalidomiders reported visiting medical and healthcare‐related facilities more frequently. A higher proportion of thalidomiders (9.2%) were unemployed, and thalidomiders tended to feel higher levels of worry and stress, especially in terms of the future. CONCLUSIONS: The results of this nationwide survey of the life situations of thalidomiders in Japan clarified their health conditions and the related associations with socioeconomic status. These findings could be expected to help improve the provision of medical and healthcare, welfare measures, and financial support for thalidomiders in the near future. John Wiley & Sons, Inc. 2019-07-24 2019-12-01 /pmc/articles/PMC7432171/ /pubmed/31339667 http://dx.doi.org/10.1002/bdr2.1558 Text en © 2019 The Authors. Birth Defects Research published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Research Articles
Hinoshita, Fumihiko
Beppu, Hiroko
Shioji, Shingo
Fujitani, Junko
Imai, Koubun
Tajima, Tsuyoshi
Tagami, Tetsuya
Ohnishi, Shin
A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report
title A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report
title_full A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report
title_fullStr A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report
title_full_unstemmed A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report
title_short A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report
title_sort nationwide survey regarding the life situations of patients with thalidomide embryopathy in japan, 2018: first report
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432171/
https://www.ncbi.nlm.nih.gov/pubmed/31339667
http://dx.doi.org/10.1002/bdr2.1558
work_keys_str_mv AT hinoshitafumihiko anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT beppuhiroko anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT shiojishingo anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT fujitanijunko anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT imaikoubun anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT tajimatsuyoshi anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT tagamitetsuya anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT ohnishishin anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT hinoshitafumihiko nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT beppuhiroko nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT shiojishingo nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT fujitanijunko nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT imaikoubun nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT tajimatsuyoshi nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT tagamitetsuya nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport
AT ohnishishin nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport